Home / Tools & Techniques
Tools & Techniques
| 2 min read
PHILADELPHIA—Bio-Rad Laboratories and Infometrix announced a new informatics application called AnalyzeIt MVP
| 3 min read
BALTIMORE—Researchers at Johns Hopkins University (JHU), the University Würzburg, and the Institute of Bioinformatics (IOB)raised significant questions about current drug development assumptions
| 3 min read
TEL AVIV, Israel—Compugen Ltd. announced it is leading a consortium to simulate the MAP-kinase pathway, a signaling pathway related to cancer
| 1 min read
TEL AVIV, Israel—The work with the SIMAP consortium and the mitogen-activated protein kinase pathway isn’t Compugen Ltd.’s only recent advance in the area of proteomics work.
| 3 min read
HOPKINTON, Mass.—With its agreement to acquire Xenogen Corp., Caliper Life Sciences has embarked on a critical stage to truly bring together in vitro and in vivo experimentation
| 2 min read
HILLSBORO, Ore.—FEI and Sidec Technologies announced a collaboration to commercialize protein tomography platforms and services
| 2 min read
SANTA CLARA, Calif.—Agilent Technologies announced at Pittcon 2006 last month a portfolio of internet-based services that promise to monitor its tools in the field.
| 3 min read
PALO ALTO, Calif.—Agilent isn’t content to simply coast on its gas-chromatography/mass spectrometry accomplishments. Now it is out to conquer the liquid chromatography/mass spectrometry (LC/MS) market, and is starting off on that path with the release of an entire new portfolio of LC/MS systems.
| 3 min read
ATLANTA—Serologicals Corp. recently announced that Chemicon International, its wholly-owned Temecula, Calif.-based subsidiary, had entered into a research and development agreement with Pittsburgh-based Cellumen to commercialize a cytotoxicity profiling panel and services designed with Chemicon’s cellular assay reagents and Cellumen’s system cell biology approach
| 2 min read
BOTHELL, Wash.—Lumera Corp., a nanotechnology company that designs proprietary molecular structures and polymer compounds for bioscience and technological applications, has executed a letter of intent with the Medical University of South Carolina (MUSC), under which the university will purchase Lumera’s recently released ProteomicProcessor Biosensor instrument.
| 3 min read
MOUNTAIN VIEW, Calif.—Seeking to deliver a cost-efficient, broad-brush toxicity screening service to large and small companies alike, Iconix Pharmaceuticals Inc. and Affymetrix Inc in early February announced a collaboration to do just that by combining the capabilities of Affymetrix’ GeneChip and Iconix’ DrugMatrix 640 compound reference database and analysis software system.
| 3 min read
MONROVIA, Calif.—With an eye to reducing adverse events, biotherapeutics company Xencor announced it signed a non-exclusive licensing deal with Eli Lilly & Co. for Xencor’s ImmunoFilter technology. Financial terms were not disclosed, but the multi-year deal will see the pharma giant gain access to immunogenicity data and software in exchange for annual fees.
